Pro Medicus (OTCMKTS:PMCUF) Shares Gap Down – What’s Next?

Pro Medicus Limited (OTCMKTS:PMCUF) shares gapped down prior to trading on Wednesday . The stock had previously closed at $134.8044, but opened at $125.90. Pro Medicus shares last traded at $125.90, with a volume of 10 shares traded.

Analysts Set New Price Targets

Separately, Jefferies Financial Group downgraded shares of Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $155.00.

Pro Medicus Stock Down 5.8%

The stock has a market capitalization of $11.91 billion and a PE ratio of 9,666.67. The stock’s 50 day moving average price is $117.54 and its 200-day moving average price is $107.21.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.